Portal de investigación
Effects of age and oligoasthenozoospermia on telomeres of sperm and blood cells.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Balmori, Carlos
- Cordova-Oriz, Isabel
- De Alba, Guillermo
- Medrano, Marta
- Jimenez-Tormo, Laura
- Polonio, Alba Maria
- Chico-Sordo, Lucia
- Pacheco, Alberto
- Garcia-Velasco, Juan A.
Grupos
Abstract
RESEARCH QUESTION: How do age and normo- or oligoasthenozoospermia affect telomere length dynamics in spermatozoa and blood? DESIGN: Sperm and blood samples were collected from a cohort of 37 men aged 25 and under and 40 men aged 40 and over, with either normozoospermia (NZ) or oligoasthenozoospermia (OAZ). Telomere length was evaluated using quantitative fluorescence in-situ hybridization. Telomerase mRNA (TERC and TERT) and shelterin (TRF1) gene expression were analysed using quantitative real-time polymerase chain reaction. TRF1 protein immunoreactivity was also evaluated using immunofluorescence. RESULTS: Mean sperm telomere length (STL) increased with age in the NZ group; older NZ men accumulated the longest telomeres (P < 0.001). In peripheral blood mononuclear cells (PBMC), mean telomere length decreased with age in NZ groups, although not reaching statistical significance. Interestingly, the younger OAZ group had the shortest mean telomere length (versus young NZ, P?=?0.0081; versus old NZ, P?=?0.0116; versus old OAZ, P?=?0.0009) and accumulated the highest percentage of short telomeres compared with the other groups (overall P?=?0.0017). Analysis of TERC and TERT mRNA expression in spermatozoa and PBMC did not show significant differences among groups. Statistically significant positive correlations were found between STL and seminal parameters in younger NZ men (P?=?0.009 for sperm count and P?=?0.007 for total progressive motility). Protein immunoreactivity of TRF1 in blood was not significantly different in all groups analysed. CONCLUSIONS: The OAZ group did not show the increase of STL with age that is seen in NZ individuals, suggesting that telomere length elongation mechanisms fail in OAZ patients. In PBMC, younger OAZ individuals showed significantly shorter mean telomere length, suggesting that this parameter could be a good biomarker of OAZ in younger OAZ patients. Telomerase gene and TRF1 mRNA expression and TRF1 protein immunoreactivity did not differ significantly between groups, and so these factors cannot be used as OAZ biomarkers.
Copyright © 2021 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 1472-6483, 1472-6491
- Tipo:
- Article
- Páginas:
- 1090-1100
- PubMed:
- 35397997
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,171 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
REPRODUCTIVE BIOMEDICINE ONLINE ELSEVIER SCI LTD
Citas Recibidas en Web of Science: 12
Documentos
- No hay documentos
Filiaciones
Keywords
- Oligoasthenozoospermia; Peripheral blood mononuclear cells; Spermatozoa, Telomerase; TRF1; Telomeres
Cita
Balmori C,Cordova I,De Alba G,Medrano M,Jimenez L,Polonio AM,Chico L,Pacheco A,Garcia JA,VARELA E. Effects of age and oligoasthenozoospermia on telomeres of sperm and blood cells. Reprod. BioMed. Online. 2022. 44. (6):p. 1090-1100. IF:4,000. (1).